
NIKA Pharmaceuticals, Inc.
Nika Pharmaceuticals, Inc., a pharmaceutical company, develops drugs for the treatment of HIV/AIDS, hepatitis B and C, rheumatoid arthritis, cancer, diabetes, and various other diseases. It offers dietary supplements and antiviral drugs, as well as thymus nuclear glycoprotein for the treatment of HIV. The company was formerly known as Centennial Growth Equities Inc. and changed its name to Nika Pharmaceuticals, Inc. in May 2022. Nika Pharmaceuticals, Inc. was incorporated in 2000 and is based in Henderson, Nevada.
Stock Performance (90 Days)
Layoff History
Recent News
Other Drug Manufacturers - Specialty & Generic Companies
View All →Frequently Asked Questions
Has NIKA PHARMACEUTICALS, INC had layoffs?
What industry is NIKA PHARMACEUTICALS, INC in?
Is NIKA PHARMACEUTICALS, INC a publicly traded company?
Where is NIKA PHARMACEUTICALS, INC headquartered?
Disclaimer
Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.
This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.
Found an error? Report it here.